OS Therapies (OSTX) news
Recent news
Os Therapies enters open market sale agreement with Jefferies - SEC filing
AInvest Wire · Aug 21, 2026My Size enters $10 mln equity purchase agreement with Square Gate Capital over 36 months - SEC filing
OS Therapies Inc. (NYSE American: OSTX) has entered into an equity purchase agreement with Square Gate Capital Master Fund, LLC-Series 3, under which the company may sell up to $15 million in shares of its common stock over a 24-month period, as disclosed in a recent SEC filing. The agreement,…
AInvest Wire · Aug 5, 2026OS Therapies - enters agreement for up to $10 mln senior secured convertible note on June 30 - SEC filing
On June 30, 2026, OS Therapies Inc. (OSTX) announced the execution of an agreement for a senior secured convertible note offering with proceeds of up to $10 million , as disclosed in a recent SEC filing. The financing structure includes terms that allow the conversion of the notes into equity under…
AInvest Wire · Jul 2, 2026Oncology drug developer OS Therapies refiles for $8M IPO
Oncology drug developer OS Therapies refiles for $8M IPO OS Therapies (OSTX), an emerging oncology drug developer specializing in treatments for bone cancer, has recently refiled for an initial public offering (IPO) of $8M [1]. This downsized offering comes amidst a wave of upward trends in the…
AInvest Wire · Jun 5, 2024Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.